MBX MBX Biosciences, Inc. Common Stock Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
09:57
Aug 21
Aug 21
A news wire reports a broad list of price target raises, cuts.
A news wire reports a broad list of price target raises, cuts, and coverage initiations across numerous stocks from various analysts, with no personal market view expressed.
13:00
Aug 17
Aug 17
Highlights largest single-fund new positions.
Highlights largest single-fund new positions for Q2 2026, no directional view.
MED
16:43
Jul 19
Jul 19
Skeptical reply noting lack of contracts and slow microcap thesis timeline.
Skeptical reply noting lack of contracts and slow microcap thesis timeline; no personal commitment or explicit direction.
LOW
00:00
Jun 24
Jun 24
UBS analyst Mike Yee named MBX as a hot takeover target alongside COGT and APGE.
UBS analyst Mike Yee named MBX as a hot takeover target alongside COGT and APGE; no personal position disclosed by author.
MED
20:05
Dec 22
Dec 22
1. THE FACT: Minervini's longs have been "performing really well." Top gainers include: $MBX.
1. THE FACT: Minervini's longs have been "performing really well." Top gainers include: $MBX, $NEM, $ATI, $ROIV, $DRD and $TSLA. "All but one of our 10 longs are positive."
2. THE BRIDGE: Strong performance and positive returns on these individual long positions indicate upward momentum and potential for continued gains, even in a market that feels "heavy" (as mentioned in tweet 4). This suggests these stocks are showing relative strength.
3. THE VERDICT: Long MBX, NEM, ATI, ROIV, DRD, and TSLA due to strong recent performance.
HIGH
About MBX Analyst Coverage
Buzzberg tracks MBX (MBX Biosciences, Inc. Common Stock) across 4 sources. 1 bullish vs 0 bearish calls from 4 analysts. Sentiment: predominantly bullish (20%). 5 total trade ideas tracked. Latest voices: DeItaone, seedy19tron, stocks_stones.